loadpatents
Patent applications and USPTO patent grants for GANCIA; Emanuela.The latest application filed is for "enzyme inhibitors".
Patent | Date |
---|---|
Enzyme Inhibitors App 20220298141 - DAVIE; Rebecca Louise ;   et al. | 2022-09-22 |
Enzyme Inhibitors App 20220298138 - DAVIE; Rebecca Louise ;   et al. | 2022-09-22 |
Cinnoline Compounds And Uses Thereof App 20220073520 - Malhotra; Sushant ;   et al. | 2022-03-10 |
Azaindoles As Inhibitors Of Hpk1 App 20210299110 - HEFFRON; Timothy ;   et al. | 2021-09-30 |
Naphthyridine Compounds And Uses Thereof App 20210277024 - Kellar; Terry ;   et al. | 2021-09-09 |
Isoquinoline Compounds And Uses Thereof App 20210253580 - Liang; Jun ;   et al. | 2021-08-19 |
Naphthyridines as inhibitors of HPK1 Grant 11,034,692 - Chan , et al. June 15, 2 | 2021-06-15 |
Isoquinolines As Inhibitors Of Hpk1 App 20210163417 - Chan; Bryan ;   et al. | 2021-06-03 |
Pyridazine derivatives as RORc modulators Grant 11,008,312 - Bronner , et al. May 18, 2 | 2021-05-18 |
Azaindoles as inhibitors of HPK1 Grant 10,952,995 - Heffron , et al. March 23, 2 | 2021-03-23 |
Azaindoles As Inhibitors Of Hpk1 App 20200000780 - HEFFRON; Timothy ;   et al. | 2020-01-02 |
Naphthyridines as inhibitors of HPK1 Grant 10,407,424 - Chan , et al. Sept | 2019-09-10 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS App 20190263794 - Bronner; Sarah M. ;   et al. | 2019-08-29 |
Pyridazine derivatives as RORc modulators Grant 10,280,144 - Fauber , et al. | 2019-05-07 |
Aryl sultam derivatives as RORc modulators Grant 10,259,808 - Fauber , et al. | 2019-04-16 |
Aryl sultam derivatives as RORc modulators Grant 10,131,644 - van Niel , et al. November 20, 2 | 2018-11-20 |
Isoquinolines As Inhibitors Of Hpk1 App 20180282282 - Chan; Bryan ;   et al. | 2018-10-04 |
Naphthyridines As Inhibitors Of Hpk1 App 20180282328 - Chan; Bryan ;   et al. | 2018-10-04 |
ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20180105516 - FAUBER; Benjamin ;   et al. | 2018-04-19 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS App 20180072683 - Fauber; Benjamin ;   et al. | 2018-03-15 |
Aryl sultam derivatives as RORc modulators Grant 9,751,873 - Fauber , et al. September 5, 2 | 2017-09-05 |
ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20170137393 - van Niel; Monique Bodil ;   et al. | 2017-05-18 |
ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20160168141 - Fauber; Benjamin ;   et al. | 2016-06-16 |
Diazacarbazoles And Methods Of Use App 20150368244 - Dyke; Hazel Joan ;   et al. | 2015-12-24 |
Methods of use of diazacarbazoles for treating cancer Grant 9,216,980 - Chen , et al. December 22, 2 | 2015-12-22 |
Benzoxazepin compounds selective for PI3K P110 delta and methods of use Grant 9,090,628 - Heffron , et al. July 28, 2 | 2015-07-28 |
ARYL SULTAM DERIVATIVES AS RORc MODULATORS App 20150197529 - Fauber; Benjamin ;   et al. | 2015-07-16 |
Methods Of Use Of Diazacarbazoles For Treating Cancer App 20150087630 - Chen; Huifen ;   et al. | 2015-03-26 |
Methods Of Use Of Diazacarbazoles For Treating Cancer App 20130261104 - Chen; Huifen ;   et al. | 2013-10-03 |
Diazacarbazoles and methods of use Grant 8,501,765 - Chen , et al. August 6, 2 | 2013-08-06 |
Isoindolones derivatives as MEK kinase inhibitors and methods of use Grant 8,492,427 - Gancia , et al. July 23, 2 | 2013-07-23 |
Benzoxazepin Compounds Selective For Pi3k P110 Delta And Methods Of Use App 20120245144 - Heffron; Timothy ;   et al. | 2012-09-27 |
Diazacarbazoles And Methods Of Use App 20110124654 - Chen; Huifen ;   et al. | 2011-05-26 |
Isoindolones Derivatives As Mek Kinase Inhibitors And Methods Of Use App 20110124622 - Gancia; Emanuela ;   et al. | 2011-05-26 |
Diazacarbazoles And Methods Of Use App 20110118230 - Chen; Huifen ;   et al. | 2011-05-19 |
Arylsulfonylnaphthalene derivatives as 5HT.sub.2A antagonists Grant 7,592,456 - Chambers , et al. September 22, 2 | 2009-09-22 |
Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists App 20070281952 - Chambers; Mark Stuart ;   et al. | 2007-12-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.